Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,079
  • Shares Outstanding, K 5,951
  • Annual Sales, $ 720 K
  • Annual Income, $ -4,030 K
  • 60-Month Beta 0.15
  • Price/Sales 22.96
  • Price/Cash Flow N/A
  • Price/Book 1.86
Trade LEXX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.60 +24.48%
on 07/26/22
3.24 -0.10%
on 08/11/22
+0.45 (+16.01%)
since 07/11/22
3-Month
1.85 +74.95%
on 05/24/22
3.49 -7.26%
on 06/28/22
+0.87 (+36.57%)
since 05/11/22
52-Week
1.85 +74.95%
on 05/24/22
7.20 -55.05%
on 09/07/21
-2.52 (-43.81%)
since 08/11/21

Most Recent Stories

More News
Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled,...

LEXX : 3.24 (+12.77%)
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic

NetworkNewsWire Editorial Coverage : In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill them. Simply put, it...

LEXX : 3.24 (+12.77%)
JAZZ : 154.25 (-2.02%)
JNJ : 167.14 (-2.07%)
UTHR : 220.41 (-0.49%)
BMY : 74.46 (-0.53%)
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic

NetworkNewsWire Editorial Coverage   New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore...

LEXX : 3.24 (+12.77%)
JAZZ : 154.25 (-2.02%)
JNJ : 167.14 (-2.07%)
UTHR : 220.41 (-0.49%)
BMY : 74.46 (-0.53%)
Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension

KELOWNA, BC / ACCESSWIRE / August 10, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that...

LEXX : 3.24 (+12.77%)
LEXXW : 0.8541 (+20.30%)
The Power of Science to Stop a Killer

NetworkNewsWire Editorial Coverage : Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million adults in this country...

LEXX : 3.24 (+12.77%)
PFE : 48.29 (-3.32%)
MRK : 88.93 (-0.29%)
AZN : 64.65 (-2.49%)
NVS : 85.58 (-2.12%)
The Power of Science to Stop a Killer

NetworkNewsWire Editorial Coverage   New York, NY – August 8, 2022 –  Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More...

LEXX : 3.24 (+12.77%)
PFE : 48.29 (-3.32%)
MRK : 88.93 (-0.29%)
AZN : 64.65 (-2.49%)
NVS : 85.58 (-2.12%)
The Power of Science to Stop a Killer

/PRNewswire/ -- Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million...

LEXX : 3.24 (+12.77%)
PFE : 48.29 (-3.32%)
MRK : 88.93 (-0.29%)
AZN : 64.65 (-2.49%)
NVS : 85.58 (-2.12%)
Lexaria Bioscience’s (NASDAQ: LEXX) Tech Helping Innovators of Today, Tomorrow

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) patented DehydraTECH(TM) has been regarded as one of the most innovative drug delivery technologies in years, proving useful in delivering a wide range of active...

LEXX : 3.24 (+12.77%)
Lexaria’s (NASDAQ: LEXX) DehydraTECH Study Completes Dosing with No Serious Adverse Events

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing with its DehydraTECH(TM)-processed cannabidiol (“DehydraTECH-CBD”) has been completed...

LEXX : 3.24 (+12.77%)
LEXXW : 0.8541 (+20.30%)
Lexaria's DehydraTECH-CBD Hypertension Study HYPER-H21-4 Dosing Complete with No Serious Adverse Events

KELOWNA, BC / ACCESSWIRE / July 27, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that dosing...

LEXX : 3.24 (+12.77%)
LEXXW : 0.8541 (+20.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules....

See More

Key Turning Points

3rd Resistance Point 3.66
2nd Resistance Point 3.45
1st Resistance Point 3.34
Last Price 3.24
1st Support Level 3.02
2nd Support Level 2.81
3rd Support Level 2.70

See More

52-Week High 7.20
Fibonacci 61.8% 5.16
Fibonacci 50% 4.53
Fibonacci 38.2% 3.89
Last Price 3.24
52-Week Low 1.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar